PATENT CLAIM ANALYSIS

Application Number: 16194070
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "450000"]

Abstract:
The present invention is to provide a liposome composition, comprising: a liposome enclosed by a phospholipid bilayer, wherein the phospholipid bilayer defines a receiving space therein; nutrients provided in the receiving space, wherein the nutrients comprising glutamic acid, docosahexaenoic acid (DHA), and lecithin; and a targeting substance embedded in or bound to the liposome. The liposome composition disclosed herein has a phospholipid bilayer and a special targeting substance that can pass through the BBB of a living body and then release nutrients, including glutamic acid, to activate glial cells in the living body, in order for the glial cells to acquire calcium ions in the living body, the goal being to promote synaptogenesis and to modulate neuronal plasticity and synaptic transmission while enhancing the glutamic acid-glutamine cycle.

Claim (Index 4):
The liposome composition of  claim 1 , wherein the nutrients further comprises a vitamin, an antioxidant, or a mixture or a complex thereof.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 98.0
- Lexical Diversity: 1.88158
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12301847', '11662172', '14265939', '14440834', '13188458']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.706129375810467
- 35 USC 102 Novelty (BERT): 0.478628083582221
- Combined Prediction Score: 0.6833792465876424
- Mean Citation Score: 147.35535199999995
- Max Citation Score: 166.06654
- Similarity Product: 119.91769109021544

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test